Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BOSTON SCIENTIFIC CORPORATION

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma

Phase 1

Terminated

Conditions: Glioblastoma Multiforme
Brain Neoplasms

Interventions: Drug: OncoGel (ReGel/Paclitaxel)

First Posted Date: 2007-05-28

Last Posted Date: 2022-06-22

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 4

Registration Number: NCT00479765

Locations: 🇺🇸
The University of Chicago Brain Tumor Center, Chicago, Illinois, United States
🇺🇸
The Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

and more 2 locations

Post-Approval Study of the NexStent Carotid Stent System and the FilterWire EZ Embolic Protection System: SONOMA

Phase 4

Terminated

Conditions: Carotid Stenosis

First Posted Date: 2007-05-25

Last Posted Date: 2012-08-07

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 298

Registration Number: NCT00478673

Locations: 🇺🇸
Huntsville Hospital Heart Center, Huntsville, Alabama, United States
🇺🇸
St. Luke's Medical Center, Phoenix, Arizona, United States
🇺🇸
Central Cardiology Medical Clinic, Bakersfield, California, United States

and more 59 locations

AIR Extension Study - Long-Term Safety of Alair Treated Subjects

Not Applicable

Completed

Conditions: Asthma

Interventions: Device: Bronchial Thermoplasty with the Alair System

First Posted Date: 2007-03-19

Last Posted Date: 2021-02-17

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 69

Registration Number: NCT00448812

Locations: 🇧🇷
Irmandade Santa Casa de Misericordia de Porto Alegre, Porto Alegre, RS, Brazil
🇨🇦
St. Joseph's Healthcare, Hamilton, Ontario, Canada
🇨🇦
Hopital Laval, Laval University, Sainte-Foy, Quebec, Canada

and more 2 locations

Safety Study of Varisolve® Procedure for Treatment of Varicose Veins in Patients With Right-to-left Cardiac Shunt

Phase 2

Completed

Conditions: Varicose Veins

Interventions: Drug: Polidocanol (1%) Microfoam (Varisolve)
Procedure: Endovenous Microfoam Occlusion

First Posted Date: 2007-03-01

Last Posted Date: 2021-04-21

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 60

Registration Number: NCT00442364

A Study of the WallFlex™ Biliary Fully-covered Stent for the Palliative Treatment of Malignant Bile Duct Obstruction

Phase 3

Completed

Conditions: Cholestasis, Extrahepatic

Interventions: Device: WallFlex™ Biliary Fully Covered Metal Stent placement

First Posted Date: 2007-02-12

Last Posted Date: 2010-06-29

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 74

Registration Number: NCT00433771

Locations: 🇺🇸
California Pacific Medical Center, San Francisco, California, United States
🇺🇸
Univ. of Colorado Health Sciences, Aurora, Colorado, United States
🇺🇸
Hennepin County Medical Center, Minneapolis, Minnesota, United States

and more 7 locations

Changes in Cerebral Blood Flow in Patients Treated With Spinal Cord Stimulation for Low Back and Leg Pain

Not Applicable

Completed

Conditions: Pain
Low Back Pain
Leg Pain

Interventions: Other: Precision Spinal Cord Stimulation and PET Scan

First Posted Date: 2007-01-04

Last Posted Date: 2022-03-31

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 15

Registration Number: NCT00418301

Locations: 🇺🇸
Center for Clinical Research, Winston-Salem, North Carolina, United States

Spinal Cord Stimulation Versus Nerve Blocks and Physical Therapy

Not Applicable

Withdrawn

Conditions: Complex Regional Pain Syndrome
Chronic Pain
Pain

Interventions: Device: Precision SCS
Procedure: Nerve Blocks and PT

First Posted Date: 2006-12-22

Last Posted Date: 2012-02-15

Lead Sponsor: Boston Scientific Corporation

Registration Number: NCT00414804

RISA Extension Study - Long Term Safety

Completed

Conditions: Asthma

Interventions: Device: Bronchial thermoplasty with the Alair System

First Posted Date: 2006-11-22

Last Posted Date: 2021-02-01

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 14

Registration Number: NCT00401986

Locations: 🇧🇷
Irmandade Santa Casa de Misericordia de Porto Alegre, Porto Alegre, RS, Brazil
🇨🇦
St. Joseph's Healthcare, Hamilton, Ontario, Canada
🇨🇦
Hospital Laval, University of Laval, Sainte-Foy, Quebec, Canada

and more 5 locations

Spinal Cord Stimulation (SCS) for Neuropathic Pain of Back or Lower Extremity

Not Applicable

Terminated

Conditions: Pain
Back Pain
Lower Extremity Pain
Intractable Neuropathic Pain

Interventions: Device: Precision for Spinal Cord Stimulation

First Posted Date: 2006-11-15

Last Posted Date: 2020-12-19

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 13

Registration Number: NCT00399841

Locations: 🇺🇸
Anesthesia Associates of Belleville, Belleville, Illinois, United States

Effect of Pulse Width With Spinal Cord Stimulation

Phase 4

Completed

Conditions: Back Pain
Pain
Chronic Pain

First Posted Date: 2006-11-15

Last Posted Date: 2012-04-04

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 21

Registration Number: NCT00399516

Locations: 🇺🇸
Comprehensive Pain Management and Rehabilitation, Daphne, Alabama, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy